bendamustine, rituximab

DRUG2 trials

Sponsors

Helse Fonna, Asan Medical Center

Conditions

Autoimmune Hemolytic AnemiaCold Agglutinin DiseaseDiffuse Large B Cell Lymphoma

Phase 2

Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease

CompletedNCT02689986

Helse FonnaAutoimmune Hemolytic Anemia, Cold Agglutinin Disease

Start: 2013-01-31End: 2016-12-31Updated: 2017-01-09

Bendamustine Plus Subcutaneous Rituximab in Patients With Diffuse Large B-cell Lymphoma

Asan Medical CenterDiffuse Large B Cell Lymphoma

Start: 2015-08-31End: 2023-08-31Target: 22Updated: 2016-04-27

Related Papers

Cold Agglutinin Disease Shows Highly Recurrent Gains of Chromosome 3, 12 and 18

Blood2019-11-131 citations

Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial

Blood2017-05-23133 citations

High Frequency of Somatic Mutations of KMT2D and CARD11 Genes in Cold Agglutinin Disease

Blood2016-12-024 citations